MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
February 05, 2024 08:50 ET
|
Mangoceuticals, Inc.
The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (a $498 value) for First 1,000 Subscribers Dallas, Texas,...
Bioidentical Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast to 2028
January 24, 2024 13:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Bioidentical Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
United States Sex Reassignment Hormone Therapy Research Report 2023: Market to Reach $2.23 Billion by 2030 - Supportive Regulations and Novel Therapies Propel Expansion
December 11, 2023 09:33 ET
|
Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "U.S. Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type...
Female Infertility Treatment Drives Demand for Human Chorionic Gonadotropin Products
September 21, 2023 08:03 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Human Chorionic Gonadotropin Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's...
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Global Finasteride Market Analysis and Forecast Report 2023-2031: Growth Opportunities in Emerging Markets
September 08, 2023 09:43 ET
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Finasteride Market By Application, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
August 10, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the...
Product Innovation Boosts Growth of Testosterone Replacement Therapy Market, Projected to Reach $1.85 Billion in 2023
July 26, 2023 04:23 ET
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Testosterone Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
July 24, 2023 09:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or Testosterone Deficiency, is proud to...
Global Hormone Therapy Market Set to Reach $23.65 Billion by 2027 with Growing Demand for Innovative Treatments and Rising Hormone Imbalance Cases
July 24, 2023 07:13 ET
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Hormone Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The market is projected to grow from $17.34...